$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table6: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period

(Tianjin, China, 1991-1999 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10Period approach, calendar periodCohort approach, calendar period
86-9091-9596-9986-9091-9596-99
C01-02Tongue52.174.669.746.959.378.2
C01-02Tongue52.174.669.746.959.378.2
C03-06Oral cavity72.662.268.458.376.261.6
C03-06Oral cavity72.662.268.458.376.261.6
C07-08Salivary gland82.082.289.460.080.887.9
C07-08Salivary gland82.082.289.460.080.887.9
C11Nasopharynx57.557.359.244.664.154.0
C11Nasopharynx57.557.359.244.664.154.0
C32Larynx59.663.867.153.367.160.5
C32Larynx59.663.867.153.367.160.5
C37-38Other thoracic organs50.448.552.536.254.948.9
C37-38Other thoracic organs50.448.552.536.254.948.9
C43Melanoma skin62.175.258.351.968.867.5
C43Melanoma skin62.175.258.351.968.867.5
C44Other skin64.987.491.965.673.290.9
C44Other skin64.987.491.965.673.290.9
C53Cervix63.464.467.157.269.363.1
C53Cervix63.464.467.157.269.363.1
C54Corpus uteri85.593.391.873.191.091.3
C54Corpus uteri85.593.391.873.191.091.3
C56Ovary30.662.866.640.756.860.3
C56Ovary30.662.866.640.756.860.3
C64Kidney41.160.061.164.554.861.5
C64Kidney41.160.061.164.554.861.5
C67Urinary bladder62.474.774.956.469.773.9
C67Urinary bladder62.474.774.956.469.773.9
C82-85+C96Non-Hodgkin lymphoma48.749.949.842.154.345.6
C82-85+C96Non-Hodgkin lymphoma48.749.949.842.154.345.6
C90Multiple myeloma22.026.051.117.325.529.3
C90Multiple myeloma22.026.051.117.325.529.3


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table5: Comparison of 5-year absolute and relative survival of cases diagnosed between 1981-1990 and 1991-1999 (Tianjin, China)
- Table6: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Tianjin, China, 1991-1999 cases followed-up until 2000)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)